Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F1W02
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,389
Award facts
- Contract value 100% obligated
- $101,389.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $101,389.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This is a competitively awarded contract with no set-aside designation and an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under the company's parent organization, Cencora, Inc. Repatha is a prescription medication used to treat high cholesterol and reduce cardiovascular risk in eligible patients.
This delivery order is issued under Cencora's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA Medical Supply Chain utilizes this contract vehicle to efficiently fulfill essential pharmaceutical requirements across military treatment facilities and veteran healthcare systems. Cencora competes on a full and open basis for federal pharmaceutical contracts, demonstrating its capability to meet rigorous government procurement standards.
Quick answers
Who was awarded contract SPE2DR26F1W02?
SPE2DR26F1W02 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1W02 worth?
The government has obligated $101,389 on SPE2DR26F1W02.
Is contract SPE2DR26F1W02 an order under another contract?
Yes. SPE2DR26F1W02 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W02 competed?
The extent of competition for SPE2DR26F1W02 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award